首页 | 本学科首页   官方微博 | 高级检索  
     

长春新碱静脉输注治疗慢性原发性血小板减少性紫癜的临床观察
引用本文:韩梅 高鹏 等. 长春新碱静脉输注治疗慢性原发性血小板减少性紫癜的临床观察[J]. 吉林医学, 2001, 22(2): 94-95
作者姓名:韩梅 高鹏 等
作者单位:吉林省人民医院!吉林长春130021
摘    要:目的:探讨长春新碱治疗慢性原发性血小板减少性紫癫的可行性。方法:设立3个观察组,对3个观察组给予长春新碱2mg持续8h静脉输注。A组:糖皮质激素治疗有禁忌症组;B组:应用糖皮质激素治疗后出现并发症组;C组:糖皮质激素治疗无效组。结果:3组共20例病例经长春新碱治疗后有效率达100%,副作用少。结论:初步观察结果表明,该疗法有效、安全、经济、适用,具有一定的临床应用价值。

关 键 词:长春新碱  血小板减少性紫癜  静脉输注
文章编号:1004-0412(2001)02-0094-02
修稿时间:2000-10-05

The clinical research about treatment for chronic primary thrombocy- topenic puripura with vincristine in keeping vein infusion
HAN Mei,GAO Peng,WANG Xue-yie. The clinical research about treatment for chronic primary thrombocy- topenic puripura with vincristine in keeping vein infusion[J]. Jilin Medical Journal, 2001, 22(2): 94-95
Authors:HAN Mei  GAO Peng  WANG Xue-yie
Abstract:Objective To find out if vincristine can be used to treat the chronic primary thrombocytopenic puripura. Method Set up 3 groups and each caes among 3 groups was given vincristine 2mg by keeping 8 hours vein infusion. Results Complete recovery is 100 %, and side-effect are seldom and not severe. Conclusion This methos is effective, safe, economic and practical, It can be used further in near future.
Keywords:Vincristine  Primary thrombocytopenic  Puripura vein infusion
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号